The First CRISPR Medicine Rewrites the Treatment of Sickle Cell DiseaseBy Maria KwiatkowskaNovember 21, 2026 In December 2023, regulators in the United States approved the first medicine based on CRISPR gene editing, a treatment for sickle cell disease.